Brief: Adaptimmune Reports Second Quarter Financial Results And Business Update

Adaptimmune Therapeutics

09/08/2021 21:03

Aug 9 (Reuters) - Adaptimmune Therapeutics PLC  ADAP.O :
    * ADAPTIMMUNE REPORTS SECOND QUARTER FINANCIAL RESULTS AND
BUSINESS UPDATE
    * ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH,
EQUIVALENTS &
MARKETABLE SECURITIES WILL FUND  CURRENT OPERATIONS INTO EARLY
2023
    * ADAPTIMMUNE THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.04
    * ADAPTIMMUNE THERAPEUTICS PLC - AS OF JUNE 30, 2021, HAD
CASH,
EQUIVALENTS OF $50.5 MILLION AND TOTAL LIQUIDITY OF $285.4
MILLION
    * ADAPTIMMUNE THERAPEUTICS PLC - QTRLY REVENUE $3.1 MILLION
    * ADAPTIMMUNE THERAPEUTICS - QTRLY REVENUE HAS INCREASED YOY
PRIMARILY DUE TO INCREASE IN DEVELOPMENT ACTIVITIES UNDER
ASTELLAS COLLABORATION AGREEMENT

Source text for Eikon:  ID:nGNX3b3mkV 
Further company coverage:  ADAP.O 

 ((Reuters.Briefs@thomsonreuters.com;))